
Gilead Sciences GILD
$ 131.28
0.33%
Annual report 2025
added 02-24-2026
Gilead Sciences EV/EBITDA Ratio 2011-2026 | GILD
Annual EV/EBITDA Ratio Gilead Sciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 8.3 | 9.44 | 16.6 | 10.4 | 9.09 | 6.06 | 5.62 | 9.93 | 26.5 | 15.6 | 8.66 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.5 | 5.62 | 11.5 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
29.4 | $ 0.87 | -0.11 % | $ 6.4 M | ||
|
Aquestive Therapeutics
AQST
|
-7.26 | $ 4.18 | 1.95 % | $ 447 M | ||
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-14.9 | $ 9.76 | 1.77 % | $ 631 M | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
4.1 | $ 96.92 | -6.31 % | $ 27.2 B | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
-21.1 | $ 21.99 | -2.05 % | $ 3.64 B | ||
|
Cerus Corporation
CERS
|
-24.7 | $ 2.89 | 42.45 % | $ 551 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-3.66 | - | - | $ 269 M | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | - | - | $ 96.9 B | ||
|
Atreca
BCEL
|
-2.76 | - | -11.76 % | $ 5.79 M | ||
|
Berkeley Lights
BLI
|
-16.9 | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
-7.96 | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
CymaBay Therapeutics
CBAY
|
-1.63 K | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
-0.721 | - | - | $ 3.74 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Caladrius Biosciences
CLBS
|
0.677 | - | -16.75 % | $ 25.8 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.0315 | - | - | $ 231 M | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-5.59 | - | -2.5 % | $ 5.88 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-1.5 | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Innate Pharma S.A.
IPHA
|
-6.65 | $ 1.44 | - | $ 235 M | ||
|
Dynavax Technologies Corporation
DVAX
|
12.8 | - | - | $ 2.02 B | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
-1.56 | - | - | $ 28.6 M | ||
|
Editas Medicine
EDIT
|
-6.41 | $ 2.88 | -4.17 % | $ 256 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 2.97 | -6.9 % | $ 4.89 M | ||
|
Edesa Biotech
EDSA
|
-1.27 | $ 18.1 | -0.96 % | $ 57.9 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
-2.63 | - | -9.21 % | $ 2.55 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
0.296 | - | -5.68 % | $ 8.28 M | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
Applied Therapeutics
APLT
|
-0.476 | - | - | $ 8.42 M | ||
|
Evogene Ltd.
EVGN
|
-1.31 | $ 0.8 | 2.56 % | $ 27.9 M | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M |